No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.

Agudo A., Sala N., Pera G., Capellá G., Berenguer A., García N., Palli D., Boeing H., Del Giudice G., Saieva C., Carneiro F., Berrino F., Sacerdote C., Tumino R., Panico S., Berglund G., Simán H., Stenling R., Hallmans G., Martínez C., Amiano P., Barricarte A., Navarro C., Quirós JR., Allen N., Key T., Bingham S., Khaw K-T., Linseisen J., Nagel G., Overvad K., Tjonneland A., Olsen A., Bueno-de-Mesquita HB., Boshuizen HC., Peeters PH., Numans ME., Clavel-Chapelon F., Boutron-Ruault M-C., Trichopoulou A., Lund E., Bläker H., Jenab M., Ferrari P., Norat T., Riboli E., González CA.